Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2008
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275082 Comprising NK3 receptor antagonist talnetant, povidone, erythritol and Sodium Lauryl Sulfate; erythritol used as soluble filler in preparation of stable drug; dosage tablet or capsule
11/06/2008US20080275078 Pyrazolo[3,4-B] Pyridine Compounds and Their Use as Pde4 Inhibitors
11/06/2008US20080275064 N-(2-Furan-2-yl-6-pyrazol-1-yl-pyrimidin-4-yl)-2-piperidin-1-yl-acetamide; antiischemic agents, antidiabetics; autoimmune diseases, Asthma, Obesity, Huntington's Disease, Dystonia, Dyskinesias, Parkinson's Disease, Inflammatory Bowl Disease
11/06/2008US20080275060 N-Hydroxyamide Derivatives and Use Thereof
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275044 Vanilloid receptor 1 antagonists; reducing a phenyl or 3-pyridyl carboxylic acid or ester to an alcohol, aziding, reduction to a primary amine, amidation with a (3-fluoro-4-methylsulfonamido)phenyl acetic acid; 2-(3-Fluoro-4-(methylsulfonamido)phenyl)-N-(substituted phenyl or pyrid-3-yl) acetamides
11/06/2008US20080275038 Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080274982 Peptide Substance Restoring Respiratory Organs Function
11/06/2008US20080274961 Respiratory system disorders; lung hypotensive agents; also pituitary adenylate cyclase activated peptide
11/06/2008US20080274506 Host cell comprising vector expressing protein fusion comprising neonatal Fc receptor for use in enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) targeting of cancer cells
11/06/2008US20080274189 Organic Compounds Comprising a Glycopyrr Onium Salt
11/06/2008US20080274105 Polypeptide variants with altered effector function
11/06/2008US20080274088 Mapc Generation of Lung Tissue
11/06/2008US20080274064 Utilization of rhinologically active substances
11/06/2008US20080274044 aqueous dispersion comprising insoluble therapeutic or diagnostic agent particles having a surface modifier; treating a respiratory illness
11/06/2008DE19702168B4 Verwendung von Extrakt aus Petasites hybridus Petasites hybridus use of extract
11/06/2008DE102007020578A1 Wässrige Aerosolzubereitungen enthaltend therapeutisch wirksame Mikroorganismen oder Teile von Mikroorganismen und Verfahren zur Erzeugung entsprechender Aerosole Aqueous aerosol preparations containing therapeutically effective microorganisms or parts of microorganisms and methods for producing corresponding aerosols
11/06/2008DE102007020492A1 Substituierte Sulfonamid-Derivate Substituted sulfonamide derivatives
11/06/2008DE102007020254A1 Use of an agent reducing the bioavailability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to prepare a medicament, especially for treating allergic diseases
11/06/2008CA2685247A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008CA2685134A1 Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008CA2685131A1 Stable solid preparation containing 4,5-epoxymorphinan derivative
11/06/2008CA2685128A1 Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008CA2682032A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988083A1 Triazole derivative
11/05/2008EP1988081A1 Binding inhibitor of sphingosine-1-phosphate
11/05/2008EP1987825A1 Pharmaceutical composition comprising oseltamivir phosphate
11/05/2008EP1987022A1 Pyridinone pyrazole urea and pyrimidinone pyrazole urea derivatives
11/05/2008EP1986952A2 Methods of treating cystic fibrosis
11/05/2008EP1986644A1 Drug combinations for the treatment of respiratory tract diseases
11/05/2008EP1986637A1 Sulfonamide derivatives for the treatment of bacterial infections
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1643953A4 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1341811B9 Orally ingestible preparation of mistletoe lectins and method
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents
11/05/2008EP1162990B1 Treatment with small peptides to effect antifibrotic activity
11/05/2008CN101300240A 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as beta 2 adrenoceptor agonists
11/05/2008CN101300239A 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as beta 2 adrenoceptor agonists
11/05/2008CN101300235A Diaminopyrimidines as P2X3 and P2X2/3 modulators
11/05/2008CN101300027A Secretory IgA and IgG antibodies-inducing agent
11/05/2008CN101300012A Diaminopyrimidine as P2X3 and P2x2/3 modulators
11/05/2008CN101297965A Applications of thymic peptide beta4 in preparing medicament for preventing and treating bronchial asthma
11/05/2008CN101297945A Medicament for treating pulmonary disease and tracheopathia and preparation method thereof
11/05/2008CN101297896A Method for extracting antipyretic and detoxicated oral liquid using cellulase
11/05/2008CN101297892A Chinese medicinal composition for treating cough and asthma due to lung-heat and respiratory tract infection of bird
11/05/2008CN101297864A Preparation of Xia sang ju formulation
11/05/2008CN101297862A Capsule for treating rhinitis
11/05/2008CN101297826A Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/05/2008CN101297812A Use of Tulathromycin compound for curing respiratory disease of fowl
11/05/2008CN101297795A Compound florfenicol powder for animals and preparation thereof
11/05/2008CN101297794A Compound kanamycin sulphate injection for dogs and preparation thereof
11/05/2008CN100430402C Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/05/2008CN100430085C Medicine for ventilating the lung and resolving phlegm to relieve cough and preparing method
11/05/2008CN100430077C Chinese medicine preparation for treating upper respiratory tract infection and preparing method
11/05/2008CN100430069C Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof
11/05/2008CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms
11/05/2008CN100430045C Radix bupleuri dripping pill and its preparing method
11/04/2008US7446175 Antibodies to human IL-1β
11/04/2008US7446123 Azabicyclo derivatives as muscarinic receptor antagonists
11/04/2008US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus
10/2008
10/30/2008WO2008131376A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/30/2008WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
10/30/2008WO2008129624A1 Pyrazolopyridine-4-yl-pyrazolone derivative, addition salt thereof and phosphodiesterase inhibitor containing the same as active ingredient
10/30/2008WO2008129263A1 Antibodies against il-25
10/30/2008WO2008128685A1 Use of a composition comprising formoterol and beclometasone dipropionate for the prevention and/or treatment of an exacerbation of asthma
10/30/2008WO2008109427A3 Anesthetic spray composition
10/30/2008WO2008088727A3 Endothelin receptor antagonists
10/30/2008WO2008076296A3 D-ribose for treating suboptimal pulmonary function
10/30/2008US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes
10/30/2008US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
10/30/2008US20080269335 Crth2 Receptor Antagonists
10/30/2008US20080269278 Treatment of Impaired Respiratory Function with Gaboxadol
10/30/2008US20080269271 Analgesics; antidepressants; neurodegenerative diseases; antiepileptic agents; cognition activators; antitussive agents; incotinence; irritable bowel syndrome; stroke; vision defects; antiinflammatory agents; skin disorders; diarrhea; eating disorders
10/30/2008US20080269267 Anticancer agents; rheumatic diseases; asthma; chronic obstructive pulmonary disease; neurodegenerative diseases; metabolic disorders
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269254 Antiproliferative agents; anticancer agents; graft versus host disease; rheumatic diseases; vision defects; cardiovascular disorders
10/30/2008US20080269235 e.g. 5-Acetyl-4-[(3,5-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one; Tumor Necrosis Factor alpha antagonist; antiinflammatory agent, autoimmune diseases; chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease
10/30/2008US20080269204 Benzolactam boronic acid compounds; blocking inflammatory cytokines and tumor necrosis ; phosphodiesterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders
10/30/2008US20080269190 Chronic obstructive pulmonary disease; asthma
10/30/2008US20080269179 Asthma, cystic fibrosis, cough, lung disease
10/30/2008US20080269176 New Salts
10/30/2008US20080269156 Antisense strand, sense strand are non-phosphorylated at the 5' and 3' termini; pulmonary, eye, microvascular, hearing disorders; target for hypoxia-inducible factor-1 that may regulate hypoxia-induced pathogenesis independent of growth factors such as VEGF
10/30/2008US20080269151 Antigen, nucleic acid that encodes fusion protein; diagnosis, prevention, therapy of tuberculosis
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 878